Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
Objective To investigate the killing effect of the recombinant oncolytic influenza virus OvFlu-GM-CSF, constructed using reverse genetics (RG) technology, in combination with chemotherapy drug, gemcitabine (GEM), against pancreatic cancer cells. Methods The recombinant oncolytic virus OvFlu-GM-C...
Saved in:
Main Authors: | MENG Zihe, XU Yongru, DENG Zhaoda |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Army Medical University
2025-01-01
|
Series: | 陆军军医大学学报 |
Subjects: | |
Online Access: | https://aammt.tmmu.edu.cn/html/202407052.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01) -
Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
by: Joseph Malinzi, et al.
Published: (2018-11-01) -
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
by: REN Jiaqiang, et al.
Published: (2024-12-01) -
Improving systemic delivery of oncolytic virus by cellular carriers
by: Ziyi Peng, et al.
Published: (2024-12-01) -
Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01)